Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.00062 | 1 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |